Analystreport

Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA) had its price target raised by analysts at Roth Capital from $14.00 to $80.00.

Hepion Pharmaceuticals, Inc.  (HEPA) 
Last hepion pharmaceuticals, inc. earnings: 11/14 05:17 pm Check Earnings Report